SUMMARy

We undertook a prospective observational cohort study in intensive care unit (ICU) patients requiring mechanical ventilation for four days or more to evaluate normal and abnormal bacterial carriage on admission detected by surveillance cultures of throat and rectum. We assessed the importance of surveillance and diagnostic cultures for the early detection of resistance to third generation cephalosporins employed as the parenteral component of the selective decontamination of the digestive tract. Finally, we sought the risk factors of abnormal carriage on admission to the ICU. During the 58-month study 621 patients were included: 186 patients (30%) carried abnormal flora including methicillin-resistant Staphylococcus aureus (MRSA) and aerobic Gram negative bacilli (AGNB) on admission to the ICU. Both MRSA and AGNB carriers were more commonly present in the hospital group of patients than in patients referred from the community (P <0.001), although overgrowth was equally present both in community and in hospital patients. The incidence of infections during ICU stay was higher in abnormal (n=120, 64.5%) than in normal carriers (n=185, 42.5%) (P <0.0001), with an odds ratio of 2.46 (95% confidence interval 1.72 to 3.51). Third generation cephalosporins covered ICU admission flora in 482 (78%) of the studied population. AGNB resistant to cephalosporins and MRSA were detected in surveillance cultures of 139 patients (22%), while the same resistant micro-organisms were identified only in 49 diagnostic samples (7.9%). Parenteral cephalosporins were modified in patients with abnormal flora (P <0.0001). One hundred and ninety-six patients received antibiotics before admission to the
(normal flora). Carriage of the 'hospital' potential pathogens including aerobic Gram-negative bacilli (AGnB) 8 and methicillinresistant Staphylococcus aureus (MRSA) in the oropharynx and gastrointestinal tract is considered abnormal in healthy individuals and it is uncommon 9 . Two studies in patients requiring treatment in the intensive care unit (ICU) showed a correlation between AGnB carriage on admission and the level of illness severity 10, 11 . This may be in part due to an increased availability of AGnB receptor sites on the digestive tract mucosa in illness 12, 13 . One third of ICU patients with an Acute Physiology and Chronic Health Evaluation II score >15 were AGnB carriers. This increased to 50% in a population with an Acute Physiology and Chronic Health Evaluation II score ≥27. Severity of illness is thought to be the most important factor in the conversion of the 'normal' to the 'abnormal' carrier state.
Risk factors for abnormal carriage of both AGnB and MRSA include chronic underlying disease, such as diabetes, chronic obstructive pulmonary disease, alcoholism, liver disease and antibiotic use [14] [15] [16] [17] [18] . In general, most risk factors associated with abnormal carriage on admission to the ICU reflect the illness severity.
Some authors report that the abnormal carrier state is not only a marker of illness but is a disease on its own 19, 20 , as overgrowth of AGnB in the gut has been shown to cause immuno-paralysis. Hence the detection of abnormal carriage on admission to the ICU may identify a subset of patients at high risk of infection and mortality.
Immediate appropriate antimicrobial therapy of pneumonia and septicaemia has been recognised to increase survival 21, 22 . Several studies have shown that when the initiation of appropriate antimicrobial treatment is delayed, patients have adverse outcomes and that the adverse prognostic implications of late or inappropriate antimicrobial treatment cannot be overcome by the correction of the initial empirical antibiotic management 23, 24 . Severe infections with multi-resistant AGnB and MRSA can be the reason for the admission to the ICU. These observations have led to the immediate administration of empirical broad-spectrum antibiotics to cover most pathogens. For example, the combination of fluoroquinolones, meropenem and vancomycin has been promoted by some authors 23, 24 . However, the overuse of antimicrobial drugs is associated with the emergence of multi-resistant bacteria 25 even when antibiotic guidelines are tailored to local flora. Selective decontamination of the digestive tract (SDD) is an antibiotic prophylaxis regimen to reduce serious infections of lower airways and bloodstream in patients requiring treatment in the intensive care setting. SDD using parenteral and enteral antimicrobials aims to control primary endogenous, secondary endogenous and exogenous infections 26, 27 . A prospective observational study was undertaken in patients requiring at least four days of mechanical ventilation and receiving the full SDD protocol to evaluate the following clinical and microbiological endpoints. First, this study was conducted to determine normal and abnormal bacterial carriage and its level by surveillance cultures collected on admission to the ICU. Second, we assessed the importance of surveillance and diagnostic cultures for the early detection of resistance to third generation cephalosporins employed as the parenteral component of SDD. Finally, we sought the risk factors related to abnormal carriage on admission to the ICU.
MATERIALS AnD METHODS
Setting
The University Hospital of Trieste is a multidisciplinary, regional referral centre. The ICU is an 11-bed facility with an annual admission rate of about 600 patients; medical and surgical patients each account for 45% of the population and 10% are trauma. The overall mortality is 10% for all admissions.
Patients
Patients aged over 18 years, admitted to the ICU and expected to require at least four days of mechanical ventilation were enrolled in the study. Data were recorded from 1 March 2000 until 31 December 2004. Patients with severe immunosuppression (organ transplantation, neutropenia <1×10 9 /l, acquired immune deficiency syndrome) were excluded because of the need for a different parenteral antibiotic protocol on admission. Patients without complete surveillance cultures due to clinical reasons could not be analysed and were also excluded. A third reason for exclusion was prolonged extubation (greater than five days) during the ICU treatment because of the discontinuation of surveillance cultures and SDD protocol. The Hospital Institutional Review Board waived the need for informed consent, because of the epidemiological nature of the study and absence of invasive procedures.
Patients were classified into 'community' and 'hospital' groups. Patients admitted to the ICU from home or the street, via the Department of Accident and Emergency, were considered to belong to the 'community' group. Patients referred to the ICU from the hospital ward, even if they stayed less than one day, were included in the 'hospital' group.
Design and endpoints
The design was a prospective observational cohort study on carriage detected by surveillance cultures 28 . Surveillance samples of throat and rectum were obtained on admission to the ICU and twice in a week thereafter until extubation. A swab with a cotton wool tip was rubbed over the tonsil area after intubation. At the same time a rectal swab was obtained. Only rectal swabs coloured by faeces were considered valid. In addition, diagnostic cultures were obtained from all patients showing signs of inflammation or infection on admission to the unit. The set of throat and rectal and diagnostic samples were sent immediately to the department of clinical microbiology where they were processed within one hour. 
Definitions
Carriage on admission to the ICU was defined as the patient condition in which the same potential pathogen was isolated from the first two sets of surveillance cultures in any concentration.
normal carriage was defined as the presence of 'community' potential pathogens including S. pneumoniae, H. influenzae, M. catarrhalis, MSSA and Candida species. The presence of E. coli was considered normal in the rectal swab but abnormal in the oropharyngeal swab if present in overgrowth 29 . Abnormal carriage was defined as the isolation of AGnB including Klebsiella, Enterobacter, Citrobacter, Morganella, Proteus, Acinetobacter, Serratia, Pseudomonas species and MRSA in throat and/or rectum in any concentration.
Overgrowth was defined as the presence of ≥3+ (semi-quantitatively) or ≥10 5 (quantitatively) colony forming units of abnormal bacteria/ml of saliva and/or gram of faeces 30 .
The level of carriage, both normal and abnormal, was expressed by the 'carriage index', defined as the sum of all semi-quantitative growth densities isolated from surveillance swabs, divided by the total number of positive swabs collected 31 . The diagnosis of infection included signs of local and/or generalised inflammation, laboratory findings and positive bacteriological diagnostic samples. Pneumonia was diagnosed based on fever 38.5°C, new pulmonary infiltrate on chest X-ray for more than 48 hours, leukocytosis (white blood cells count >12000 /ml) or leukopenia (white blood cells count <4000 /ml), purulent tracheal aspirate with semiquantitative cultures at a threshold of ≥3+ colony forming units. Tracheo-bronchitis was diagnosed when all above signs were present but normal chest radiography was found. Urinary tract infection was defined as freshly voided catheter urine containing 10 5 colony forming units/ml and ≥5 leukocytes per high-power-light microscope field. Bloodstream infection was diagnosed in the presence of clinical signs of generalised inflammation and one positive blood culture. A second positive blood culture for the same strain was required when the first blood culture yielded low level pathogenic micro-organisms (i.e. coagulase-negative staphylococci). Catheterrelated bloodstream infection was diagnosed when the same potential pathogenic micro-organism was cultured from the intravascular device and from the blood samples. Wound infection was defined by local signs of inflammation, purulent discharge from the wound site with culture yielding ≥3+ and ≥++ leukocytes. The isolation of skin flora was considered contamination. Intra-abdominal infection covered either solid organ or peritoneal cavity (localised or diffuse). Peritonitis was diagnosed according to clinical conditions, ultrasound and/ or computed tomography scan and/or laparotomy findings associated with microbiological positive samples (micro-organism ≥3+ and leukocytes ≥++).
A patient diagnosed as infected in the first 48 hours was considered infected on admission. Using the criterion of carriage, infections were classified into endogenous and exogenous. An exogenous infection was caused by a potential pathogen not present in the surveillance cultures. Endogenous infection was due to a micro-organism carried by the patient in throat and/or rectum. Primary endogenous were infections caused by community (normal) or hospital (abnormal) micro-organisms already carried by the patient on admission to the ICU. Micro-organisms acquired during the ICU stay but not present on admission caused secondary endogenous infections 32 .
Patients were considered on antibiotic therapy before admission to the ICU when antimicrobials were administered for more than 24 hours.
Antibiotic policy
All patients studied received selective decontamination of the digestive tract using enteral and parenteral antimicrobials from admission until extubation 28 . Half a gram of a paste containing polymyxin E 2%, tobramycin 2% and amphotericin B 2% was applied in the lower cheeks and 9 ml of a suspension containing 100 mg of polymyxin E, 80 mg of tobramycin, 500 mg of amphotericin B was administered through the nasogastric tube four times daily. The combination of polymyxin and tobramycin covers all AGnB including Proteus, Morganella and Serratia species being the gap in the spectrum of the polymyxins. Additionally, polymyxin is active against Pseudomonas and Acinetobacter resistant to beta-lactams, aminoglycosides, fluoroquinolones, beta-lactam plus beta-lactamase inhibitors and carbapenems.
A third generation cephalosporin was chosen as the parenteral component of SDD. Patients who belonged to the 'community' group received cefotaxime (100 mg/kg/day via intravenous continuous infusion for four days 33 ) to cover community respiratory pathogens such as S. pneumoniae, H. influenzae, M. catarrhalis, MSSA. Amongst the normal flora only Candida is naturally resistant to cefotaxime. Ceftazidime (100 mg/kg/day via intravenous continuous infusion for four days 33 ) was given to patients classified as belonging to the hospital group because they were considered to be exposed to abnormal AGnB such as P. aeruginosa.
Antimicrobials were administered according to the hospital guidelines based on site of infection and culture results. The parenteral antimicrobials of SDD were continued after the fourth day when patients were infected and the causative microorganisms were sensitive. Failure of the parenteral component of SDD was defined as any change of third generation cephalosporins following the results of surveillance or diagnostic cultures and/or clinical deterioration within 48 to 72 hours.
Microbiology
Surveillance samples of throat and rectal swabs were processed qualitatively and semi-quantitatively, to detect the level of carriage. Three solid mediaMacConkey, staphylococcal and yeast agar -were inoculated using the four-quadrant method combined with brain-heart infusion broth. Each swab was streaked onto the three solid media, then the tip was broken off into 5 ml of enrichment broth. The MacConkey plate was examined after one night and the staphylococcal and yeast plates after two nights. In addition, if the enrichment broth was turbid after one night's incubation it was then inoculated onto the three media. A semi-quantitative estimation was made by grading growth density on a scale of 1+ to 5+ 34 . Standard methods for identification, typing and sensitivity patterns were used for all microorganisms.
To differentiate S. aureus from other species of staphylococci, the laboratory used production of DnAse (by a DnA agar-plate method) and a slideagglutination test to detect clumping factor and protein A (Pastorex Staph Plus, Sanofi Diagnostics, Marnes, France). If the results were inconclusive, a tube-coagulase test with the nCTC 6571 strain as a positive control was done and interpreted at four and 24 hours. A coagulase-negative staphylococcus was identified by a negative tube-coagulation test.
S. aureus isolates were tested for methicillin susceptibility by subculturing the isolates onto nutrient agar plus 5% salt (Oxoid, Basingstoke, UK) with a strip containing 25 µg of methicillin. S. aureus isolates growing up to the strip and subsequently shown to have an MIC >256 g/ml on gradient plates in the exponential antibiotic gradient test (E-test), were confirmed to be MRSA. The breakpoints for vancomycin resistance amongst enterococci was 16 µ/ml and 8 µ/ml for S. aureus with intermediate sensitivity to vancomycin.
Database
The data collected included age, gender, illness severity using SAPS II score, diagnostic category (medical, surgical and trauma) on ICU admission. Duration of previous hospital stay, antibiotic treatment before ICU admission, normal and abnormal carrier state on admission, length of ICU stay, length of mechanical ventilation, incidence of infection in ICU and ICU mortality were put into the database (Excel for Windows ® , Microsoft, Redmond, USA).
In cases where an identical micro-organism was carried at both oropharyngeal and rectal sites by the same patient, that particular micro-organism was counted once only.
Statistical analysis
Descriptive statistics were used to describe demographics, health status and other variables related to ICU admission, carrier state and antibiotic usage. nominal or categorical data were tabulated in 2×2 or 2×k contingency tables. The difference between proportions was tested using the χ 2 test with Satterthwaite approximation in case of unequal variances. The difference between means was tested using the unpaired t-test for independent samples. Two-tailed P values were reported. non-normally distributed variables (i.e. ICU stay) were log transformed.
To estimate the relative probability of abnormal carriage to prior use of antibiotics we calculated the odds ratio (OR) and its 95% confidence interval (CI) by means of non-conditional logistic regression, univariate or multivariate. In the multivariate model age, SAPS II score (four categories: <30; 30 to 39; 40 to 49; >50), diagnostic category on ICU admission (medical vs non medical) and infection on ICU admission were included 35 . Analyses were performed using SAS software (SAS Institute Inc., Cary, USA). 
RESULTS
General characteristics and infection on admission to the intensive care unit
A total of 1926 patients were admitted to the unit between 1 March 2000 and 31 December 2004. Information was recorded on 656 severely ill patients admitted to the ICU. Thirty-five patients were not included in the analysis because they did not fulfil the inclusion criteria due to incomplete surveillance (n=18), prolonged extubation (n=11) and immunosuppression (n=6). A total of 621 patients, accounting for 11,693 patients' days on the ICU and 10,084 mechanical ventilation days, were analysed (Table 1 ). The mean age of the total population was 59 years and the mean SAPS II was 43.9; 48% of the population was medical. Of the overall population, 326 (52.5%) patients were referred from the hospital ward and 196 (31.6%) received antibiotics before ICU admission. The mean length of stay on the hospital ward was 11.8 (SD±15.5) days; the mean length of ICU stay was 19.1 (SD±17.4) days in both community and hospital groups. About half of the total population was infected: 22% on admission and 27% during the treatment on ICU. The patients in the hospital group were significantly older (mean age 64.7, SD±13.6) compared with those referred from the community (mean age 52.5, SD±20.2) (P <0.0001). There were significantly more medical admissions in the hospital group (n=221, 68%) compared to the community group (n=75, 25%) (P <0.0001).
Twenty (6.7%) patients belonging to the community group were infected on admission to the ICU compared with 117 (35.8%) patients belonging to the hospital group (P <0.001) ( Table 2 ). A total of 70 patients (seven community, 63 hospital) were infected with abnormal bacteria on admission to the ICU. Remarkably, Pseudomonas species caused infection in 24.8% of the hospital group. Table 2 shows the micro-organisms causing infection diagnosed on admission in 137 patients and their resistance to third generation cephalosporins.
Normal and abnormal carriage on admission to the intensive care unit.
Seventy percent (n=435) of the study population carried normal flora and 30% (n=186) abnormal flora. A total of 283 patients (45.6%) carried yeasts. There were significantly more hospital patients who carried Candida species on admission to ICU (n=181, 55.5%) compared to the community patients (n=102, 34.6%) (P <0.0001). A total of 51 (8.2%) patients carried MSSA, 25 and 26 in the community and hospital groups, respectively. Out of the total population, 67 (11%) patients carried MRSA on admission. There were 62 (19%) MRSA carriers in the hospital group compared to five (1.7%) in the community group (P <0.0001). One hundred and forty (22%) patients had surveillance cultures positive for AGnB in their admission flora (Table 1 ). There were significantly more AGnB carriers in the hospital group (n=98, 30.1%) than in the community group (n=42, 14.2%) (P <0.0001) ( Table 1 ). The three most common AGnB isolated were P. aeruginosa, and E. coli in the oropharynx, and Enterobacter species.
In the univariate analysis, patients who carried abnormal flora had a higher risk of infection, both overall (OR 2.46; 95% CI 1.72 to 3.51) and on admission to the intensive care (OR 2.9; 95% CI 2 to 4.4), compared to normal carriers. Primary endogenous infections were significantly more observed in patients with abnormal flora on admission than in the normal flora group (45.6% vs 22.8%, P <0.0001) ( Table 3) .
Detection of overgrowth on admission to the intensive care unit
normal and abnormal flora were present in overgrowth concentrations in both community and hospital groups. Mean values of carriage indices of MSSA were 3.2 (±1 SD) and 3.3 (±1.01 SD) in the community and in the hospital group, respectively. E. coli was detected at mean index value of 3.6 (±0.92 SD) in patients coming from the community and 3.6 (±0.96 SD) in patients referred from the wards. Mean carriage indices of MRSA were 3.4 (±0.87 SD) and 3.5 (±0.88 SD) in the community and hospital groups respectively. Finally, the mean carriage indices of AGnB were 3.6 (±0.87 SD) in the community group and 3.5 (±0.88 SD) in the hospital group. In particular the indices of P. aeruginosa were 3.3 (±1.15 SD) and 3.5 (±0.9 SD) Diagnostic samples identified 49 (7.9%) patients with bacteria resistant to third generation cephalosporins (MRSA n=22, resistant AGnB n=27).
The administration of third generation cephalosporins was modified on clinical grounds in two of the 70 patients who were normal carriers and infected on admission to the ICU (2.9%) ( Table 3) . In contrast, the abnormal carriers infected on admission required changing 36 times in 67 patients (53.7%) (P <0.0001).
Analysis of risk factors for abnormal carriage
Antibiotics were administered on the wards before admission to the ICU in 196 (60%) patients (Table 1) and 82 (41.8%) carried ceftazidime resistant AGnB. The most common antimicrobials employed were beta-lactams (63%), followed by quinolones (11%), glycopeptides (8%) and metronidazole (8%).
Abnormal carriage on admission to the ICU was associated with previous antibiotic usage (OR 3.24; 95% CI 2 to 5.26) and infection on admission to the unit (OR 1.7; 95% CI 2 to 5.26) at univariate analysis. The multivariate analysis demonstrated that only previous antibiotic treatment was associated with abnormal carriage (OR 3.5; 95% CI 2.1 to 5.8).
DISCUSSIOn
Four findings emerge from this prospective observational cohort study including 621 severely ill patients over approximately five years:
• Thirty percent of the study population carried abnormal flora on arrival to ICU; 22 and 11% carried AGnB and MRSA, respectively. AGnB and MRSA carriers were significantly more present in the hospital group than in the community group. • Overgrowth of both 'normal' and 'abnormal' flora was present on admission; 70.8 and 83.5% of the patients who had overgrowth of normal and abnormal potential pathogens, respectively, developed primary endogenous infections.
• Bacteria resistant to third generation cephalosporins used as the parenteral component of SDD, including MRSA and AGnB, were present in surveillance cultures to a higher extent (threefold) than in the diagnostic samples.
• Antibiotic usage before the admission to the ICU was found to be a risk factor for abnormal carriage.
The patients who were admitted to the ICU as abnormal carriers belonged mainly to the population referred to the unit from the wards (75%) ( Table 3) . MRSA and AGnB carriers were significantly more common in the hospital group. Although the hospital group was significantly older and included more medical patients, known to suffer from chronic underlying diseases, than the community group, the multivariate analysis failed to confirm illness severity as a risk factor for abnormal carriage. Only previous antibiotic usage was shown to promote abnormal carriage in the multivariate analysis.
This study showed that the parenteral component of SDD, i.e. cefotaxime or ceftazidime, was not modified in the majority of patients admitted to the ICU with normal flora and developing a subsequent infectious episode. The immediate administration of broad-spectrum antimicrobials on admission has been shown to improve survival 21, 22 and recent literature recommends a broad-spectrum antibiotic combination, to cover multi-resistant AGnB and MRSA in patients admitted from the hospital 23, 24 . Our study shows that only a subset of patients with previous antimicrobial treatment requires broadspectrum antibiotics, as patients from the community and without previous antibiotic treatment were admitted to the ICU carrying normal flora.
Abnormal carriers of AGnB and MRSA had overgrowth concentrations on ICU admission. Overgrowth has been shown to be an independent risk factor for both pneumonia and septicaemia [36] [37] [38] [39] . For example, once P. aeruginosa is present ≥10 5 in the oropharynx the chance that identical Pseudomonas is isolated from the lower airways is 50% 40 . In a pancreatitis study gut overgrowth was associated with infection of the necrotic tissue of the pancreas 37 . There was a significant correlation between overgrowth of MRSA in the surveillance cultures and diagnostic samples positive for MRSA in a recent epidemiological study 38 . Small intestinal overgrowth is required for yeasts to translocate through the gut mucosa lining into the gutassociated lymphoid tissue and blood 39 . Our data show that the subset of patients with overgrowth on admission is at risk of primary endogenous infection of internal organs. Control of overgrowth using enteral polymyxin/tobramycin, and amphotericin B or nystatin, with or without vancomycin, has been shown to prevent colonisation and infection of internal organs by potential pathogens [37] [38] [39] . A recent meta-analysis of randomised controlled trials confirms that a short course of a parenteral antibiotic combined with enteral antimicrobials significantly reduces pneumonia (OR 0.35; CI 0.29 to 0.41) and mortality (OR 0.78; CI 0.68 to 0.89) 26 . In our study cefotaxime or ceftazidime were administered for four days as the parenteral component of SDD. Additionally, the enteral component of SDD was equally effective in both normal and abnormal carriers as the incidence of secondary endogenous infections was low, i.e. 12.4% and 9.7%, respectively.
In this study, 22% of the total population were carriers of resistant bacteria in their throat and gut admission flora, while 7.9% had diagnostic cultures positive for resistant bacteria, showing that surveillance swabs are more sensitive for the identification of the abnormal and resistant microorganisms, especially when diagnostic samples are negative. Our observation confirms the results of an American study in which 18% of patients carried resistant AGnB in their admission flora, while only 5% of patients had resistant AGnB in diagnostic cultures 18 . Previous antibiotic usage has been recognised to promote abnormal carriage with resistant AGnB and MRSA. Hence, ceftazidime, as the parenteral component of SDD, may be less useful and may require adjusting into more broad-spectrum antibiotics, to cover resistant strains causing infections on admission. Most SDD trials employed cefotaxime; parenteral ceftazidime was administered in two trials 41, 42 and fluoroquinolones in three studies [43] [44] [45] . After finishing this study we have decided to adjust the parenteral component of SDD by replacing ceftazidime with imipenem plus vancomycin only in patients who received antimicrobials before admission to the ICU due to the presence of MRSA and pseudomonal resistance problems on the wards of our hospital. The addition of enteral antibiotics cleared carriage of resistant bacteria on our intensive care resulting in the interesting observation that the wards of our hospital have a higher resistance problem compared with the ICU.
We acknowledge that the results of this study may not be generalisable to different clinical settings, as the microbial ecology of the community and wards may be different from our cohort. However, this study showed that the knowledge of the patient's carrier state on ICU admission is important for the distinction between normal and abnormal carriage, resistance at an early stage and subsequent appropriate antibiotic therapy. Furthermore, the knowledge of abnormal resistant carriage at an early stage could be relevant for the application of preventive strategies, i.e. the isolation of patients carrying multi-resistant strains and high levels of hygiene.
COnCLUSIOnS
Our study shows that the knowledge of carriage using surveillance cultures is useful to the intensivist for three reasons. First, surveillance cultures allowed identification of abnormal carriage and resistant strains at an early stage, particularly when diagnostic samples were negative. Second, third generation cephalosporins used as the parenteral component of SDD were effective in about 80% of the studied population avoiding the immediate administration of broad-spectrum antimicrobials. Systemic antibiotics were modified mainly in the abnormal flora group who received antibiotic therapy before ICU admission. Third, our finding of overgrowth being present on admission may justify the immediate administration of enteral antibiotics as part of SDD.
